Patents by Inventor Atsushi Shimazaki

Atsushi Shimazaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210330654
    Abstract: A preventive or therapeutic agent for glaucoma or ocular hypertension includes a combination of isopropyl (6-{[4-(pyrazol-1-yl)benzyl] (pyridin-3-ylsulfonyl) aminomethyl}pyridin-2-ylamino)acetate with one or more other preventive or therapeutic drugs for glaucoma or ocular hypertension, with the proviso that tafluprost is excluded.
    Type: Application
    Filed: June 25, 2021
    Publication date: October 28, 2021
    Applicant: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: Tomoko KIRIHARA, Atsushi SHIMAZAKI, Masatsugu NAKAMURA
  • Patent number: 10761786
    Abstract: A communication apparatus is provided which includes a control unit configured to perform control so that an execution frequency of predetermined communication in a state in which a connection using a communication method other than a Neighbor Awareness Network is established is lower than an execution frequency of the predetermined communication in a state in which a connection using the communication method other than the Neighbor Awareness Network is not established.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: September 1, 2020
    Assignee: Canon Kabushiki Kaisha
    Inventor: Atsushi Shimazaki
  • Publication number: 20200252784
    Abstract: A communicating apparatus includes a first communication unit configured to communicate with an external apparatus using a first wireless communication method, and a second communication unit configured to communicate with an external apparatus using a second wireless communication method different from the first wireless communication method. The second communication unit searches for an external apparatus which communicates by the second wireless communication method using a wireless channel used in communication by the first communication unit, and connects to the external apparatus.
    Type: Application
    Filed: April 24, 2020
    Publication date: August 6, 2020
    Inventor: Atsushi Shimazaki
  • Publication number: 20200206200
    Abstract: The object of the present invention is to find a new application of isopropyl (6-{ [4-(pyrazol-1-yl)benzyl] (pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate or a salt thereof. Isopropyl (6-{ [4-(pyrazol-1-yl)benzyl] (pyridin-3-ylsulfonyl) aminometh yl}pyridin-2-ylamino) acetate or a salt thereof is useful as a therapeutic agent for a disease involving a greatly elevated intraocular pressure.
    Type: Application
    Filed: March 11, 2020
    Publication date: July 2, 2020
    Applicant: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: Tomoko KIRIHARA, Atsushi SHIMAZAKI, Najam A. SHARIF
  • Patent number: 10667117
    Abstract: A communicating apparatus includes a first communication unit configured to communicate with an external apparatus using a first wireless communication method, and a second communication unit configured to communicate with an external apparatus using a second wireless communication method different from the first wireless communication method. The second communication unit searches for an external apparatus which communicates by the second wireless communication method using a wireless channel used in communication by the first communication unit, and connects to the external apparatus.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: May 26, 2020
    Assignee: CANON KABUSHIKI KAISHA
    Inventor: Atsushi Shimazaki
  • Publication number: 20200085804
    Abstract: A composition for preventing or treating glaucoma or ocular hypertension including a combination of isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl) aminomethyl} pyridin-2-ylamino) acetate and at least one other drug for preventing or treating glaucoma or ocular hypertension, with the proviso that tafluprost is excluded.
    Type: Application
    Filed: September 23, 2019
    Publication date: March 19, 2020
    Applicant: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: Tomoko KIRIHARA, Atsushi SHIMAZAKI, Masatsugu NAKAMURA
  • Publication number: 20190235801
    Abstract: A communication apparatus is provided which includes a control unit configured to perform control so that an execution frequency of predetermined communication in a state in which a connection using a communication method other than a Neighbor Awareness Network is established is lower than an execution frequency of the predetermined communication in a state in which a connection using the communication method other than the Neighbor Awareness Network is not established.
    Type: Application
    Filed: January 15, 2019
    Publication date: August 1, 2019
    Inventor: Atsushi Shimazaki
  • Patent number: 10244055
    Abstract: Issues are addressed by providing a communication apparatus including a setting unit configured to execute a communication setting for operating the communication apparatus in a direct connection state without the intermediation of an external apparatus while specification processing is not executed for specifying whether or not the communication apparatus operates as an apparatus that determines a channel used for a direct connection with a terminal apparatus without the intermediation of the external apparatus in a case where a reception unit receives a setting command including a predetermined command.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: March 26, 2019
    Assignee: Canon Kabushiki Kaisha
    Inventor: Atsushi Shimazaki
  • Publication number: 20180200239
    Abstract: The object of the present invention is to find a new application of isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate or a salt thereof. Isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate or a salt thereof is useful as a therapeutic agent for a disease involving a greatly elevated intraocular pressure.
    Type: Application
    Filed: July 7, 2016
    Publication date: July 19, 2018
    Applicant: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: Tomoko KIRIHARA, Atsushi SHIMAZAKI, Najam A. SHARIF
  • Publication number: 20180084399
    Abstract: A communicating apparatus includes a first communication unit configured to communicate with an external apparatus using a first wireless communication method, and a second communication unit configured to communicate with an external apparatus using a second wireless communication method different from the first wireless communication method. The second communication unit searches for an external apparatus which communicates by the second wireless communication method using a wireless channel used in communication by the first communication unit, and connects to the external apparatus.
    Type: Application
    Filed: November 29, 2017
    Publication date: March 22, 2018
    Inventor: Atsushi Shimazaki
  • Patent number: 9867029
    Abstract: A communicating apparatus includes a first communication unit configured to communicate with an external apparatus using a first wireless communication method, and a second communication unit configured to communicate with an external apparatus using a second wireless communication method different from the first wireless communication method. The second communication unit searches for an external apparatus which communicates by the second wireless communication method using a wireless channel used in communication by the first communication unit, and connects to the external apparatus.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: January 9, 2018
    Assignee: CANON KABUSHIKI KAISHA
    Inventor: Atsushi Shimazaki
  • Publication number: 20170339737
    Abstract: Issues are addressed by providing a communication apparatus including a setting unit configured to execute a communication setting for operating the communication apparatus in a direct connection state without the intermediation of an external apparatus while specification processing is not executed for specifying whether or not the communication apparatus operates as an apparatus that determines a channel used for a direct connection with a terminal apparatus without the intermediation of the external apparatus in a case where a reception unit receives a setting command including a predetermined command.
    Type: Application
    Filed: May 17, 2017
    Publication date: November 23, 2017
    Inventor: Atsushi Shimazaki
  • Publication number: 20170311148
    Abstract: A communicating apparatus includes a first communication unit configured to communicate with an external apparatus using a first wireless communication method, and a second communication unit configured to communicate with an external apparatus using a second wireless communication method different from the first wireless communication method. The second communication unit searches for an external apparatus which communicates by the second wireless communication method using a wireless channel used in communication by the first communication unit, and connects to the external apparatus.
    Type: Application
    Filed: July 11, 2017
    Publication date: October 26, 2017
    Inventor: Atsushi Shimazaki
  • Patent number: 9756671
    Abstract: A communication mode for performing wireless connection of a communicating apparatus is decided based on a first command for performing wireless connection and a second command received following the first command.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: September 5, 2017
    Assignee: CANON KABUSHIKI KAISHA
    Inventor: Atsushi Shimazaki
  • Patent number: 9730045
    Abstract: A communicating apparatus includes a first communication unit configured to communicate with an external apparatus using a first wireless communication method, and a second communication unit configured to communicate with an external apparatus using a second wireless communication method different from the first wireless communication method. The second communication unit searches for an external apparatus which communicates by the second wireless communication method using a wireless channel used in communication by the first communication unit, and connects to the external apparatus.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: August 8, 2017
    Assignee: CANON KABUSHIKI KAISHA
    Inventor: Atsushi Shimazaki
  • Patent number: 9692934
    Abstract: A communicating apparatus receives a request command which requires a response, and determines whether the communication mode of a partner apparatus corresponding to the request command matches a communication mode executed by the self communicating apparatus. If it is determined that the communication mode of the partner apparatus matches the communication mode executed by the self communicating apparatus, the communicating apparatus transmits a response command to the request command. If it is determined that the communication mode of the partner apparatus does not match the communication mode executed by the self communicating apparatus, the communicating apparatus transmits no response command to the request command.
    Type: Grant
    Filed: August 16, 2016
    Date of Patent: June 27, 2017
    Assignee: Canon Kabushiki Kaisha
    Inventors: Atsushi Shimazaki, Takashi Moriya
  • Publication number: 20160360065
    Abstract: A communicating apparatus receives a request command which requires a response, and determines whether the communication mode of a partner apparatus corresponding to the request command matches a communication mode executed by the self communicating apparatus. If it is determined that the communication mode of the partner apparatus matches the communication mode executed by the self communicating apparatus, the communicating apparatus transmits a response command to the request command. If it is determined that the communication mode of the partner apparatus does not match the communication mode executed by the self communicating apparatus, the communicating apparatus transmits no response command to the request command.
    Type: Application
    Filed: August 16, 2016
    Publication date: December 8, 2016
    Inventors: Atsushi Shimazaki, Takashi Moriya
  • Patent number: 9448753
    Abstract: A communicating apparatus receives a request command which requires a response, and determines whether the communication mode of a partner apparatus corresponding to the request command matches a communication mode executed by the self communicating apparatus. If it is determined that the communication mode of the partner apparatus matches the communication mode executed by the self communicating apparatus, the communicating apparatus transmits a response command to the request command. If it is determined that the communication mode of the partner apparatus does not match the communication mode executed by the self communicating apparatus, the communicating apparatus transmits no response command to the request command.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: September 20, 2016
    Assignee: CANON KABUSHIKI KAISHA
    Inventors: Atsushi Shimazaki, Takashi Moriya
  • Publication number: 20160228421
    Abstract: A composition for preventing or treating glaucoma or ocular hypertension including a combination of isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl} pyridin-2-ylamino) acetate and at least one other drug for preventing or treating glaucoma or ocular hypertension, with the proviso that tafluprost is excluded.
    Type: Application
    Filed: April 19, 2016
    Publication date: August 11, 2016
    Applicant: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: Tomoko KIRIHARA, Atsushi SHIMAZAKI, Masatsugu NAKAMURA
  • Patent number: 9339496
    Abstract: A composition for treating or preventing glaucoma or ocular hypertension including a isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate and a beta-receptor antagonist, in a combined pharmaceutically acceptable amount. As for the administration form, these drugs may be administered concomitantly or may be administered as a combination drug.
    Type: Grant
    Filed: July 11, 2013
    Date of Patent: May 17, 2016
    Assignee: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: Tomoko Kirihara, Atsushi Shimazaki, Masatsugu Nakamura